Type 1 gaucher disease - clinical features

Gaucher Disease

Volumn , Issue , 2006, Pages 155-173

  Mistry, Pramod K ^a   Zimran, Ari ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547712746     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420005509     Document Type: Chapter

References (78)

1. Cox, T.M. and Schofield, J.P., Gaucher’s disease: clinical features and natural history, Baillieres Clin Haematol, 10(4), 657, 1997.
2. Beutler, E. and Grabowski, G.A., Gaucher Disease, Scriver CR, B.A., Sly W.S. et al., Eds., New York: McGraw-Hill, 2001.
3. Grabowski, G.A. et al., Gaucher Disease: Phenotypic and Genetic Variation, Scriver CR, B.A., Sly W.S. et al., Ed., McGraw-Hill, New York, 2006.
4. Zimran, A. et al., Survey of hematological aspects of Gaucher disease, Hematology, 10(2), 151, 2005.
5. Zimran, A. et al., Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients, Medicine (Baltimore), 71(6), 337, 1992.
6. Sibille, A. et al., Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications, Am J Hum Genet, 52, 1094, 1993.
7. Lee, R.E., The pathology of Gaucher disease, Prog Clin Biol Res, 95, 177, 1982.
8. Pastores, G.M. et al., Therapeutic goals in the treatment of Gaucher disease, Semin Hematol, 41(4 Suppl 5), 4, 2004.
9. Charrow, J. et al., The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease, Arch Intern Med, 160(18), 2835, 2000.
10. Sidransky, E., Gaucher disease: complexity in a “simple” disorder, Mol Genet Metab, 83, 6, 2004.
11. Grabowski, G.A., Gaucher disease: gene frequencies and genotype/phenotype correlations, Genet Test, 1(1), 5, 1997.
12. Neudorfer, O. et al., Occurrence of Parkinson’s syndrome in type I Gaucher disease, QJM, 89(9), 691, 1996.
13. Sidransky, E., Gaucher disease and parkinsonism, Mol Genet Metab, 84(4), 302, 2005.
14. Zimran, A. et al., Prediction of severity of Gaucher’s disease by identification of mutations at DNA level, Lancet, 2(8659), 349, 1989.
15. Ida, H. et al., Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients, Blood Cells Mol Dis, 24(1), 73, 1998.
16. Maaswinkel-Mooij, P. et al., The natural course of Gaucher disease in The Netherlands: implications for monitoring of disease manifestations, J Inherit Metab Dis, 23(1), 77, 2000.
17. Aerts, J.M. and Hollak, C.E., Plasma and metabolic abnormalities in Gaucher’s disease, Baillieres Clin Haematol, 10(4), 691, 1997.
18. Deegan, P.B. et al., Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease, Blood Cells Mol Dis, 35(2), 259, 2005.
19. Barton, N.W. et al., Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease, Proc Natl Acad Sci U.S.A., 87(5), 1913, 1990.
20. Maas, M. et al., Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging - initial experience, Radiology, 229(2), 554, 2003.
21. Maas, M. et al., Quantification of skeletal involvement in adults with type I Gaucher’s disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter, AJR Am J Roentgenol, 179(4), 961, 2002.
22. Goker-Alpan, O. et al., Divergent phenotypes in Gaucher disease implicate the role of modifiers, J Med Genet, 42(6), e37, 2005.
23. Svennerholm, L., Hakansson, G., Mansson, J.E., and Nilsson, O., Chemical differentiation of the Gaucher subtypes, Prog Clin Biol Res, 95, 231, 1982.
24. Mankin, H.J., Rosenthal, D.I., and Xavier, R., Gaucher disease. New approaches to an ancient disease, J Bone Joint Surg Am, 83-A(5), 748, 2001.
25. Barton, D.J. et al., Resting energy expenditure in Gaucher’s disease type 1: effect of Gaucher’s cell burden on energy requirements, Metabolism, 38(12), 1238, 1989.
26. Grabowski, G.A., Gaucher disease: Gene frequencies and genotype/phenotype correlations., Genet Testing, 1, 5, 1997.
27. Beutler, E. et al., Gaucher disease: gene frequencies in the Ashkenazi Jewish population, Am J Hum Genet, 52(1), 85, 1993.
28. Sidransky, E., Tayebi, N., and Ginns, E.I., Diagnosing Gaucher disease. Early recognition, implications for treatment, and genetic counseling, Clin Pediatr (Phila), 34(7), 365, 1995.
29. Grabowski, G.A., Leslie, N., and Wenstrup, R., Enzyme therapy for Gaucher disease: the first 5 years, Blood Rev, 12(2), 115, 1998.
30. Weinreb, N.J. et al., Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry, Am J Med, 113(2), 112, 2002.
31. Gielchinsky, I. et al., Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease, Br J Haematol, 106(3), 812, 1999.
32. Elstein, D., Abrahamov, A., Hadas-Halpern, I., and Zimran, A., Gaucher’s disease, Lancet, 358(9278), 324, 2001.
33. Grabowski, G.A. et al., Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements, Eur J Pediatr, 163, 58, 2004.
34. Gillis, S. et al., Platelet function abnormalities in Gaucher disease patients, Am J Hematol, 61(2), 103, 1999.
35. Eapen, M., Hostetter, M., and Neglia, J.P., Massive splenomegaly and Epstein-Barr virus-associated infectious mononucleosis in a patient with Gaucher disease, J Pediatr Hematol Oncol, 21(1), 47, 1999.
36. Kolodny, E.H. et al., Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients, Prog Clin Biol Res, 95, 33, 1982.
37. Neudorfer, O. et al., Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients, Am J Hematol, 55, 28, 1997.
38. Dweck, A. et al., Wandering spleen in a young girl with Gaucher disease, Isr Med Assoc J, 3(8), 623, 2001.
39. Aharoni, D., Hadas-Halpern, I., Elstein, D., and Zimran, A. Huge subcapsular splenic hematoma in a patient with Gaucher disease, Isr Med Assoc J, 2(1), 61, 2000.
40. Turfaner E. et al., Gaucher disease and brucella: just a mere coincidence? Genet Couns, 14, 363, 2003.
41. Gupta, M.K. et al., Littoral cell angioma of the spleen in a patient with Gaucher disease, Am J Hematol, 68, 61, 2001.
42. Dawson, A. et al., Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome, Ann Intern Med, 125(11), 901, 1996.
43. James, S.P., Stromeyer, F.W., Stowens, D.W., and Barranger, J.A., Gaucher disease: hepatic abnormalities in 25 patients, Prog Clin Biol Res, 95, 131, 1982.
44. Lachmann, R.H. et al., Massive hepatic fibrosis in Gaucher’s disease: clinico-pathological and radiological features, QJM, 93(4), 237, 2000.
45. Xu, R. et al., Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature, Semin Liver Dis, 25(2), 226, 2005.
46. de Fost, M. et al., Increased incidence of cancer in adult Gaucher disease in Western Europe, Blood Cells Mol Dis, Oct. 2005 (Epub ahead of print).
47. Patlas, M. et al., Multiple hypoechoic hepatic lesions in a patient with Gaucher disease, J Ultrasound Med, 21(9), 1053, 2002.
48. Margalit, M. et al., Immunomodulation by β-glucosylceramide, Presented at Int. Symp. on Immune Mediated Diseases, Moscow, September 3-7, 2005.
49. Rosenbaum, H. and Sidransky, E., Cholelithiasis in patients with Gaucher disease, Blood Cells Mol Dis, 28(1), 21, 2002.
50. Ben Harosh-Katz, M. et al., Increased prevalence of cholelithiasis in Gaucher disease association with splenectomoy but not with gilbert syndrome, J Clin Gastro 38(7), 586, 2004.
51. Zimran, A. et al., Survey of hematological aspects of Gaucher disease, Hematology, 10, 151, 2005.
52. Gielchinsky, Y. et al., High prevalence of low serum vitamin B12 in a multi-ethnic Israeli population, Br J Haematol, 115(3), 707, 2001.
53. Gillis, S. et al., Platelet function abnormalities in Gaucher disease patients, Am J Hematol, 61, 103, 1999.
54. Zimran, A. et al., Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy, Am J Hematol, 43, 69, 1993.
55. Zimran, A. et al., Rheological determinants in patients with Gaucher disease and internal inflammation, Am J Hematol., 75, 190, 2004.
56. Bax, B.E. et al., Haemorheology in Gaucher disease, Eur J Haematol, 75(3), 252, 2005.
57. Bembi, B. et al., Bone complications in children with Gaucher disease, Br J Radiol, 75(Suppl 1), A37, 2002.
58. Hermann, G., Pastores, G.M., Abdelwahab, I.F., and Lorberboym, A.M., Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement., Skeletal Radiol, 26, 687, 1997.
59. Pastores, G.M. et al., Bone density in Type 1 Gaucher disease, J Bone Miner Res, 11, 1801, 1996.
60. Wenstrup, R.J. et al., Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy, Blood, 104(5), 1253, 2004.
61. Jmoudiak, M. et al., Iliopsoas hematoma in a young patient with type I Gaucher disease, Isr Med Assoc J, 5(9), 673, 2003.
62. Itzchaki, M. et al., Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy, Acta Orthop Scand, 75(6), 641, 2004.
63. Kerem, E. et al., Pulmonary function abnormalities in type I Gaucher disease, Eur Respir J, 9(2), 340, 1996.
64. Miller, A., Brown, L.K., Pastores, G.M., and Desnick, R.J., Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease, Clin Genet, 63(5), 368, 2003.
65. Mistry, P.K. et al., Pulmonary hypertension in type 1 Gaucher’s disease: genetic and epigenetic determinants of phenotype and response to therapy, Mol Genet Metab, 77(1-2), 91, 2002.
66. Banjar, H., Pulmonary involvement of Gaucher’s disease in children: a common presentation in Saudi Arabia, Ann Trop Paediatr, 18(1), 55, 1998.
67. Goitein, O. et al., Lung involvement and enzyme replacement therapy in Gaucher’s disease, Qjm, 94(8), 407, 2001.
68. Amir, G and Ron N., Pulmonary pathology in Gaucher’s disease, Hum Pathol, 30, 666-70, 1999.
69. Elstein, D. et al., Echocardiographic assessment of pulmonary hypertension in Gaucher’s disease, Lancet, 351(9115), 1544, 1998.
70. Lachmann, R.H. et al., Massive hepatic fibrosis in Gaucher’s disease: clinico-pathological and radiological features, QJM, 93(4), 237, 2000.
71. Hoeper, M.M. et al., Pulmonary hypertension after splenectomy? Ann Intern Med, 130(6), 506, 1999.
72. Becker-Cohen, R. et al., A comprehensive assessment of renal function in patients with Gaucher disease, Am J Kidney Dis, 46(5), 837, 2005.
73. Shiran, A., Brenner, B., Laor, A., and Tatarsky, I., Increased risk of cancer in patients with Gaucher disease, Cancer, 72, 219, 1993.
74. Rosenbloom, B.E. et al., Gaucher disease and cancer incidence: a study from the Gaucher Registry, Blood, 105(12), 4569, 2005.
75. Zimran, A. et al., Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic, Blood Cells Mol Dis, 34(3), 197, 2005.
76. de Fost, M. et al., Increased incidence of cancer in adult Gaucher disease in Western Europe, Blood Cells Mol Dis, 2005.
77. Granovsky-Grisaru, S. et al., Gynecologic and obstetric aspects of Gaucher’s disease: a survey of 53 patients, Am J Obstet Gynecol, 172(4 Pt 1), 1284, 1995.
78. Elstein, Y. et al., Pregnancies in Gaucher disease: a 5-year study, Am J Obstet Gynecol. 190, 435, 2004.